Table 1 Baseline clinical and demographic characteristics of the studied population
From: Efficacy of ozone therapy on visual evoked potentials in diabetic patients
Baseline variables | Treatment arm (N = 30) | Control arm (N = 30) | P-value |
|---|---|---|---|
Age (years) | |||
 Mean ± SD | 60.8 ± 9.2 | 61.7 ± 9.6 | N.S |
 40–49 | 5 (16.7) | 5 (16.7) | N.S |
 50–59 | 8 (26.67) | 7 (23.3) | |
 60–69 | 11 (36.7) | 12 (40) | |
 70–79 | 5 (16.7) | 4 (13.3) | |
 80+ | 1 (3.3) | 2 (6.7) | |
Sex | |||
 Male | 17 (56.7) | 16 (53.3) | |
 Female | 13 (43.3) | 14 (46.7) | |
Duration of DM (days)—(mean ± SD) | 14.2 ± 6.7 | 14.4 ± 6.9 | N.S |
BMI (kg/m2)—(mean ± SD) | 27.7 ± 4.7 | 27.6 ± 3.9 | N.S |
HbA1C (%)—(mean ± SD | 9.04 ± 1.46 | 8.96 ± 1.54 | N.S |